Astellas Makes Leadership Changes
This article was originally published in Scrip
Astellas Pharma Inc. has appointed Martin Golden senior vice president and head of marketing strategy, and Frank Hudson has been promoted to senior vice president and head of budget and control, medical and development at the company. Having previously held leadership roles at Novartis AG, Johnson & Johnson and Bristol-Myers Squibb, Golden has been vice president government affairs for Astellas US since 2014. Hudson previously held financial leadership roles at Agensys, MannKind Corporation and GlaxoSmithKline plc. In addition, the company has announced three promotions: Walt Johnston, Mark Reisenauer and Kenton Stewart have been promoted to senior vice presidents, with responsibility for commercial activities in the US in urology and hospital, oncology and hospital and health systems, respectively.Johnston has been with Astellas since 2008 and most recently was vice president of US marketing and strategic new product planning and prior to this, he was at Pfizer Inc. Before Astellas, Reisenauer held various roles at Abbott, Pharmacia, Bristol-Myers Squibb and AstraZeneca PLC. Stewart has held a range of leadership roles at Astellas and most recently was responsible for US health systems.